In this study, we demonstrated that dual knockdown of mitochondrial ribosomal proteins MRPS7 and MRPS23 not only exerts intrinsic anti-tumor effects but also synergizes with cisplatin to enhance therapeutic outcomes. Here, MRPS7 is linked to neoplasm.